[Treatment of degenerative joint and spinal diseases using Eumotol].
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008297:Male; D008314:Malonates / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010659:Phenylhydrazines / Q000009:adverse effects / Q000627:therapeutic use*; D013122:Spinal Diseases / Q000188:drug therapy*
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D008314:Malonates; D010659:Phenylhydrazines
Zur Behandlung degenerativer Gelenk- und Wirbelsäulenerkrankungen mit Eumotol.